2.26
Health Catalyst Inc stock is traded at $2.26, with a volume of 1.17M.
It is up +0.00% in the last 24 hours and up +18.65% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$2.29
Open:
$2.29
24h Volume:
1.17M
Relative Volume:
0.80
Market Cap:
$167.37M
Revenue:
$302.48M
Net Income/Loss:
$-265.26M
P/E Ratio:
-0.6082
EPS:
-3.716
Net Cash Flow:
$-2.76M
1W Performance:
+15.08%
1M Performance:
+18.65%
6M Performance:
-8.40%
1Y Performance:
-42.03%
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HCAT
Health Catalyst Inc
|
2.265 | 153.70M | 302.48M | -265.26M | -2.76M | -3.716 |
|
VEEV
Veeva Systems Inc
|
194.04 | 31.31B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
69.12 | 13.55B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
61.23 | 10.82B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
97.72 | 7.97B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
HNGE
Hinge Health Inc
|
89.93 | 6.50B | 646.34M | -512.40M | 202.76M | -6.6871 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-18-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-27-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-08-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
Price to sales forward of Health Catalyst, Inc – NASDAQ:HCAT - TradingView
Health Catalyst Company Profile & Introduction - Moomoo
Discover Health Catalyst And 2 More Promising Penny Stocks - simplywall.st
Health Catalyst, PubMatic, and PTC Stocks Trade Up, What You Need To Know - Yahoo Finance
HCATHealth Catalyst Inc Options - Finviz
Health Catalyst, Inc.(NasdaqGS: HCAT) dropped from Russell 2000 Index - marketscreener.com
Health Catalyst, Inc.(NasdaqGS: HCAT) dropped from Russell 2000 Value Benchmark - marketscreener.com
Health Catalyst, Inc.(NasdaqGS: HCAT) dropped from Russell 3000E Index - marketscreener.com
Health Catalyst, Inc.(NasdaqGS: HCAT) dropped from Russell 3000E Value Benchmark - marketscreener.com
Health Catalyst, Inc.(NasdaqGS:HCAT) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
Health Catalyst Inc (HCAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
HCAT Maintained by Wells Fargo -- Price Target Raised to $1.75 - GuruFocus
Health Catalyst Inc (HCAT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
What's Driving the Recent Buzz Around Health Catalyst (HCAT) and ZoomInfo (ZI) Stocks - Kavout | AI
Data Analytics Stocks Q1 Highlights: Health Catalyst (NASDAQ:HCAT) - Yahoo Finance
Health Catalyst, Zoom, and Autodesk Shares Are Falling, What You Need To Know - Yahoo Finance
Ryan L. Vardeman discloses investment at Health Catalyst with 6.7% stake - TradingView
Palogic reports 6.7% Health Catalyst (HCAT) stake and outlines possible actions - Stock Titan
Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains? - Yahoo Finance
Health Catalyst Inc (HCAT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Health Catalyst Inc (HCAT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Health Catalyst Inc (HCAT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Health Catalyst Inc (HCAT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Health Catalyst Inc (HCAT) Institutional Confidence - TradingKey
Health Catalyst to Participate in Upcoming Investor Conference - The Manila Times
Health Catalyst and Paycom shares are falling, what you need to know - MSN
Health Catalyst and Paycom Shares Are Falling, What You Need To Know - Yahoo Finance
AI ROI: real vs hype in healthcare, Health Catalyst CEO on June 24 panel - Stock Titan
Health Catalyst Inc Stock (US42226A1079): Quarterly earnings put the data analytics specialist back - Ad-hoc-news.de
Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation - Healthcare IT Today
Health Catalyst jumps on announcement to sell Vitalware to Med‑Metrix for $147M - MSN
Health Catalyst (HCAT) CEO uses 34,485 shares to cover RSU tax bill - Stock Titan
HCAT News | HEALTH CATALYST INC (NASDAQ:HCAT) - ChartMill
Health Catalyst (HCAT) Form 144: 34,485 restricted shares planned sale 06/10/2026 - Stock Titan
Health Catalyst, Tenable, and Pegasystems Stocks Trade Down, What You Need To Know - Yahoo Finance
Health Catalyst to Cut 9% of Workforce - Moomoo
Whetstone updates Health Catalyst (HCAT) ownership to 4.5% stake - Stock Titan
Latham & Watkins Advises Health Catalyst on Divestiture of Vitalware - Legal Desire Media and Insights
Health Catalyst, Inc. - MLQ.ai
HCAT's Vitalware sale brings relief, and a reckoning - Axios
Health Catalyst Inc (HCAT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Veru And 2 Other Intriguing Penny Stocks To Watch - simplywall.st
Med-Metrix to acquire Vitalware to strengthen net revenue yield - ROI-NJ
3 Russell 2000 Stocks That Fall Short - The Globe and Mail
Health Catalyst to Divest Vitalware Unit for $147M to Med-Metrix - HIT Consultant
Health Catalyst to Sell Vitalware for $147 Million; Shares Rise Pre-Bell - Moomoo
Health Catalyst to sell Vitalware unit for $147 million cash By Investing.com - Investing.com Nigeria
Med-Metrix, LLC entered into a definitive agreement to acquire Vitalware, LLC from Health Catalyst, Inc.. - marketscreener.com
Health Catalyst (HCAT) Divests Vitalware for $147 Million - GuruFocus
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):